myriad's bracanalysiscdx for patients with her2-negative metastatic breast cancer
Published 6 years ago • 5.1K plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:29
bracanalysis cdx approved by fda for metastatic breast cancer
-
0:40
dr. lewin, precise™ oncology solutions by myriad genetics
-
2:02
dr. garner describes the myriad myrisk hereditary cancer test
-
1:16
addition of riskscore to myriad's myrisk hereditary cancer test
-
0:35
how myrisk riskscore helps providers and patients
-
0:56
myriad genetics at 2019 sabcs
-
2:16
myriad urosuite™ explainer video
-
1:19
precise oncology solutions: nicole lambert
-
7:17
hi-precision diagnostics - myriad myrisk overview
-
1:12
myriad genetics at 2018 san antonio breast cancer symposium
-
1:48
myriad genetics at asco 2023
-
6:12
what you need to know about genetics and your risk for hereditary cancer.
-
1:36
jerry lanchbury, phd, describes myriad's hrd test
-
3:54
myrisk with riskscore for all ancestries
-
3:01
myriad genetics at 2022 san antonio breast cancer symposium
-
0:32
announcement for hereditary cancer - myriad genetics
-
0:52
the value of myrisk riskscore
-
1:00
prolaris and questions about prostate cancer
-
1:13
riskscore validation at 2017 sabcs